Foltz I N, Lee J C, Young P R, Schrader J W
The Biomedical Research Centre, The University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada.
J Biol Chem. 1997 Feb 7;272(6):3296-301. doi: 10.1074/jbc.272.6.3296.
The mammalian mitogen-activated protein (MAP) kinase homologue p38 has been shown to be activated by pro-inflammatory cytokines as well as physical and chemical stresses. We now show that a variety of hemopoietic growth factors, including Steel locus factor, colony stimulating factor-1, granulocyte/macrophage-colony stimulating factor, and interleukin-3, activate p38 MAP kinase and the downstream kinase MAPKAP kinase-2. Furthermore, although these growth factors activate both p38 MAP kinase and Erk MAP kinases, we demonstrate using a specific inhibitor of p38 MAP kinase, SB 203580, that p38 MAP kinase activity was required for MAP kinase-activated protein kinase-2 activation. Conversely p38 MAP kinase was shown not to be required for in vivo activation of p90(rsk), known to be downstream of the Erk MAP kinases. Interleukin-4 was unique among the hemopoietic growth factors we examined in failing to induce activation of either p38 MAP kinase or MAP kinase-activated protein kinase-2. These findings demonstrate that the activation of p38 MAP kinase is involved not only in responses to stresses but also in signaling by growth factors that regulate the normal development and function of cells of the immune system.
哺乳动物的丝裂原活化蛋白(MAP)激酶同系物p38已被证明可被促炎细胞因子以及物理和化学应激激活。我们现在发现,多种造血生长因子,包括Steel位点因子、集落刺激因子-1、粒细胞/巨噬细胞集落刺激因子和白细胞介素-3,均可激活p38 MAP激酶和下游激酶MAPKAP激酶-2。此外,尽管这些生长因子同时激活p38 MAP激酶和Erk MAP激酶,但我们使用p38 MAP激酶的特异性抑制剂SB 203580证明,p38 MAP激酶活性是MAP激酶激活的蛋白激酶-2激活所必需的。相反,已知p90(rsk)是Erk MAP激酶的下游,体内激活p90(rsk)并不需要p38 MAP激酶。在我们检测的造血生长因子中,白细胞介素-4很独特,它不能诱导p38 MAP激酶或MAP激酶激活的蛋白激酶-2的激活。这些发现表明,p38 MAP激酶的激活不仅参与对应激的反应,还参与调节免疫系统细胞正常发育和功能的生长因子的信号传导。